Geographical distribution of A seropositive myasthenia gravis population

Vitamin D nutritional policy needs a vision for the future

(2011) Anthony W Norman et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Epidemiology of myasthenia gravis in Norway

(2010) Ardis Storm-Mathisen   ACTA NEUROLOGICA SCANDINAVICA

A systematic review of population based epidemiological studies in Myasthenia Gravis

(2010) Aisling S Carr et al.   BMC Neurology

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis

(2010) Jeffrey T Guptill et al.   CURRENT OPINION IN NEUROLOGY

Myasthenia gravis requiring pyridostigmine treatment in a national population cohort

(2010) J. B. Andersen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

SEROPOSITIVE MYASTHENIA GRAVIS: A NATIONWIDE EPIDEMIOLOGIC STUDY

(2009) A. T. Heldal et al.   NEUROLOGY

Norwegian Sami differs significantly from other Norwegians according to their HLA profile

(2009) H. F. Harbo et al.   TISSUE ANTIGENS

Myasthenia Gravis in the Elderly

(2008) Johan A. Aarli   Annals of the New York Academy of Sciences

IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†

(2008) Maria Isabel Leite et al.   BRAIN